ADGRE1 and pancreatic neoplasm: In particular, the addition of ablation to CP4 immunotherapy significantly increased IL-6, Adgre1, Cd64, Ly6a2 and Ly6c2 in the MT4 pancreatic tumors (Figure S15A-E), indicating a population of monocytes and macrophages was particularly enhanced by this combination treatment.